Discovery Topics

Swiss Innovation News

Swiss Innovation Essentials is your daily digest curating the most insightful news hand-picked by top trusted experts in the industry.

Discovery Topics

Top news of the week: 04.05.2022.

#SwissTech
#TrustValleyCH
#Tech4Trust
#cybersecurity
#digitalTrust
#VDTech
#VLeadersMedtech
#lncRNA
#oncology
#cardiac

Swiss Innovation

@eugen12 shared
On May 2, 2022
RT @TrustValleyCH: Proud of our #Tech4Trust Alumni! High Potential Canon for Ketl. Learn more: https://t.co/pF4hYYuxrf #TrustValleyCH #digitalTrust #cybersecurity @CanonEMEA https://t.co/k7gDyY91l8
Open
Trust Valley’s Post

Trust Valley’s Post

High potential Canon partnership for Ketl 🚀🚀🇨🇭🌍  Japanese multinational corporation Canon EMEA recently announced on LinkedIn its partnership with... 14 comments on LinkedIn

@Innovaud shared
On May 3, 2022
RT @venturelab_ch: The road to Boston: the Venture Leaders Medtech 2022 kick-off their international roadshow. Review of the Swiss National Startup Team meeting in Lausanne: https://t.co/diPZOuuwPa #VLeadersMedtech https://t.co/8uX4Gtlf0y
Open
The road to Boston: The Venture Leaders Medtech 2022 kick-off their international roadshow

The road to Boston: The Venture Leaders Medtech 2022 kick-off their international roadshow

In June, the ten Venture Leaders Medtech 2022 will represent Switzerland and pitch their solutions in Boston, USA. During their weeklong roadshow, the entrepreneurs will meet with ...

@FIT_fund shared
On Apr 28, 2022
RT @Innovaud: Limula, making cell therapies accessible to all patients 👩‍⚕️ Founded by two @epflalumni, Limula has developed a platform for the automated production of personalised therapies to make these accessible to everyone in need 👉 https://t.co/xObHt1s4w3 @FIT_fund #VDTech #SwissTech https://t.co/MJdBfXZLBd
Open
Limula, making cell therapies accessible to all patients

Limula, making cell therapies accessible to all patients

Founded at the end of 2020 by two EPFL Alumni, Luc Henry and Yann Pierson, Limula has developed a platform for the automated production of personalised therapies. The Vaud-based …

@startuptickerCH shared
On May 3, 2022
RT @HAYA_lncRNA: We're excited to announce that @Innosuisse is supporting two research collaboration projects between HAYA and @unibern, University Hospital of Bern (@inselgruppe), and @CHUVLausanne exploring #lncRNA therapies for #cardiac and #oncology applications: https://t.co/RBE00k8HAB https://t.co/0X45Xuvhey
Open
HAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies

HAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies

View our Press Release here.

@swissnexBoston shared
On May 3, 2022
With the two-week spring #startup bootcamp underway, join us in highlighting our newest campers. First, meet Josua Woerlen of 9T Labs and Rodrigo Fraga-Silva of Comphya. Learn more about them and the other startups participating https://t.co/XXvB2YVzR5 and stay tuned for more! https://t.co/BwlQbzOhhj
Open
Seven Swiss Startups to Explore the US Market

Seven Swiss Startups to Explore the US Market

Connecting Switzerland, North America and the world in science, education, innovation and art.

@startuptickerCH shared
On May 3, 2022
Engimmune Therapeutics raises CHF 15.5 million in seed financing https://t.co/D2dZEbsD3y https://t.co/Px7b6ybHTJ
Open
Engimmune Therapeutics raises CHF 15.5 million in seed financing

Engimmune Therapeutics raises CHF 15.5 million in seed financing

Less than one year following its incorporation, Basel based Engimmune therapeutics developing novel T-cell receptor (TCR)-based therapeutics has finalised its seed round. To …

@swissnexChina shared
On May 3, 2022
#NEWSLETTER: 𝗠𝗮𝘆 𝟮𝟬𝟮𝟮 𝗮𝘁 𝗦𝘄𝗶𝘀𝘀𝗻𝗲𝘅 𝗶𝗻 𝗖𝗵𝗶𝗻𝗮 👉Get the latest scoop >> https://t.co/Cqvy4mbSZw 👉Sign up here >> https://t.co/Bzz5r4oT3c https://t.co/RehyJTvcLF
Open
View this email in your browser

View this email in your browser

Join us in this special edition of Café des Sciences co-organized with the Consulate General of Switzerland in Chengdu. Postponement Swiss Alumni China 2022 In response to the …

@EPFL_Park shared
On Apr 28, 2022
🚀🚀🚀 EPFL and Sonceboz, innovating side-by-side. Learn more: https://t.co/noGvNYem9h #Swisstech https://t.co/0OQUDLMH4P
Open
EPFL and Sonceboz, innovating side-by-side

EPFL and Sonceboz, innovating side-by-side

26.4.2022 – In March 2016, the EPFL welcomed Sonceboz, a Swiss company founded in 1936 and specializing in mechatronic drive systems for demanding environments, which has set up its ...

Read more: Swiss Innovation
weekly 04.05.2022
View archives
Back to home

Subscribe to Discovery Topics - Swiss Innovation.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Discovery Topics - Swiss Innovation.
Privacy Policy

Sign up for the weekly Discovery Topics - Swiss Innovation newsletter

Never again miss anything or anyone that matter in Discovery Topics

Sign up and receive the Discovery Topics - Swiss Innovation weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy